LivaNova PLC - Detailed Introduction, Company Background, Business Scope, Financial Data, and Market Performance

More Details of LivaNova PLC Company

LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the design, development, manufacture, marketing and selling of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula and other related accessories. It includes the Essenz Perfusion System, the Company’s next-generation HLM with an embedded patient monitor for tailored patient care strategies. Neuromodulation segment is engaged in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). The ACS segment is engaged in the development, production, and sale of temporary life support products.

LivaNova PLC Info



Ticker SymbolLIVN

Company nameLivaNova PLC

IPO dateOct 19, 2015

CEOMr. Vladimir A. Makatsaria

Number of employees2900

Security typeOrdinary Share

Fiscal year-endOct 19

Address20 Eastbourne Terrace

CityLONDON

Stock exchangeNASDAQ Global Select Consolidated

CountryUnited Kingdom

Postal codeW2 6LG

Phone442033250662

Websitehttps://www.livanova.com/

Ticker SymbolLIVN

IPO dateOct 19, 2015

CEOMr. Vladimir A. Makatsaria

Company Executives of LivaNova PLC



Name

Name/Position

Position

Shareholding

Change

Mr. William A. Kozy

Independent Chairman of the Board

32.57K

+15.05%

Mr. Alex Shvartsburg

Chief Financial Officer

26.68K

--

Ms. Stephanie Bolton

President, Global Epilepsy

12.75K

--

Dr. Sharon O'Kane, Ph.D.

Independent Director

11.30K

+19.06%

Mr. Todd C. Schermerhorn

Independent Director

9.06K

+49.63%

Mr. Francesco Bianchi

Independent Director

9.03K

-14.25%

Franco Poletti ,

President, Cardiopulmonary Business Unit

8.52K

+4.49%

Ms. Brooke Story

Independent Director

6.48K

+86.48%

Mr. Michael Damon Hutchinson

Senior Vice President, Chief Legal Officer, Company Secretary

5.67K

--

Ahmet Tezel

Senior Vice President, Chief Innovation Officer

1.94K

--

Name

Name/Position

Position

Shareholding

Change

Mr. William A. Kozy

Independent Chairman of the Board

32.57K

+15.05%

Mr. Alex Shvartsburg

Chief Financial Officer

26.68K

--

Ms. Stephanie Bolton

President, Global Epilepsy

12.75K

--

Dr. Sharon O'Kane, Ph.D.

Independent Director

11.30K

+19.06%

Mr. Todd C. Schermerhorn

Independent Director

9.06K

+49.63%

Mr. Francesco Bianchi

Independent Director

9.03K

-14.25%

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

No Data

By RegionUSD

Name

Revenue

Proportion

United States

188.47M

53.46%

Rest of World

97.27M

27.59%

Europe

66.78M

18.94%

By Business

By Region

No Data

Shareholding Stats

Updated: Tue, Aug 19

Shareholders

Shareholder Types

Shareholders

Proportion

BlackRock Institutional Trust Company, N.A.

11.67%

PRIMECAP Management Company

8.50%

The Vanguard Group, Inc.

4.47%

Millennium Management LLC

4.44%

State Street Investment Management (US)

3.81%

Other

67.10%

Shareholders

Proportion

BlackRock Institutional Trust Company, N.A.

11.67%

PRIMECAP Management Company

8.50%

The Vanguard Group, Inc.

4.47%

Millennium Management LLC

4.44%

State Street Investment Management (US)

3.81%

Other

67.10%

Shareholder Types

Shareholders

Proportion

Investment Advisor

47.30%

Investment Advisor/Hedge Fund

34.79%

Hedge Fund

15.49%

Research Firm

2.72%

Pension Fund

2.17%

Bank and Trust

1.36%

Individual Investor

0.36%

Sovereign Wealth Fund

0.09%

Insurance Company

0.04%

Institutional Shareholding



Updated: Sun, Oct 5

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q3

561

56.75M

103.93%

-8.11M

2025Q2

564

56.85M

104.11%

-6.95M

2025Q1

581

56.61M

103.82%

-8.04M

2024Q4

586

56.98M

104.84%

-8.56M

2024Q3

563

55.15M

101.56%

-9.48M

2024Q2

546

57.21M

105.64%

-8.52M

2024Q1

547

58.00M

107.51%

-6.90M

2023Q4

532

56.62M

105.11%

-7.28M

2023Q3

527

56.14M

104.20%

-8.51M

2023Q2

529

55.56M

103.33%

-9.55M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

BlackRock Institutional Trust Company, N.A.

6.37M

11.67%

-150.58K

-2.31%

Jun 30, 2025

PRIMECAP Management Company

4.64M

8.5%

+32.94K

+0.71%

Jun 30, 2025

The Vanguard Group, Inc.

2.44M

4.47%

-214.69K

-8.09%

Jun 30, 2025

Millennium Management LLC

2.43M

4.44%

+360.76K

+17.47%

Jun 30, 2025

State Street Investment Management (US)

2.08M

3.81%

-17.41K

-0.83%

Jun 30, 2025

AQR Capital Management, LLC

2.05M

3.75%

+478.52K

+30.45%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

1.61M

2.96%

+282.33K

+21.20%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.43M

2.62%

+18.55K

+1.31%

Jun 30, 2025

Wellington Management Company, LLP

1.28M

2.34%

+805.32K

+170.32%

Jun 30, 2025

Artisan Partners Limited Partnership

1.25M

2.29%

+661.48K

+112.86%

Jun 30, 2025

Related ETFs



Updated: Sun, Nov 2

Name

Proportion

SPDR S&P Health Care Equipment ETF

1.52%

JPMorgan Active Small Cap Value ETF

1.19%

Federated Hermes MDT Small Cap Core ETF

0.56%

Invesco NASDAQ Future Gen 200 ETF

0.45%

Global X Aging Population ETF

0.41%

Simplify Health Care ETF

0.4%

iShares US Small Cap Value Factor ETF

0.36%

Avantis US Small Cap Equity ETF

0.33%

iShares U.S. Medical Devices ETF

0.33%

First Trust Active Factor Mid Cap ETF

0.32%

SPDR S&P Health Care Equipment ETF

Proportion1.52%

JPMorgan Active Small Cap Value ETF

Proportion1.19%

Federated Hermes MDT Small Cap Core ETF

Proportion0.56%

Invesco NASDAQ Future Gen 200 ETF

Proportion0.45%

Global X Aging Population ETF

Proportion0.41%

Simplify Health Care ETF

Proportion0.4%

iShares US Small Cap Value Factor ETF

Proportion0.36%

Avantis US Small Cap Equity ETF

Proportion0.33%

iShares U.S. Medical Devices ETF

Proportion0.33%

First Trust Active Factor Mid Cap ETF

Proportion0.32%

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split



Date

Type

Ratio

No Data

Date

Type

Ratio

No Data